HIMS 241129 22.00C (HIMS241129C22000) Stock Options, News & Quotes

3.40
+0.55+19.30%

15min DelayClose Nov 22 15:59 ET

3.51High1.92Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Tamages

1 hour ago

$Hims & Hers Health (HIMS.US)$
up nearly 4% in overnight trading following Trump’s nomination of Marty Makary as Head of the FDA.
Dr. Makary currently serves as the Chief Medical Officer of Sesame, a telehealth platform that also offers compounded versions of GLP-1s.

Bitcoin 100k

6 hours ago

Pre market +4%

$Hims & Hers Health (HIMS.US)$ started my 1st position last week at 19.60. I first spoted this when it hit new ATH at 30 but was big sell off on Amzn news. It was a blessing. Last week i was up +30%. And we stop at previous high at 25.
Pre market is 26.35 +3.6%. Strong start to potentially revisit 30 this week.

102496198

9 hours ago

$Hims & Hers Health (HIMS.US)$ Trageg 45 based on cup and handle pattern.

Xrobertm

Yesterday 05:30

$HIMS

Bullish Report on HIMS (Hims & Hers Health Inc.)
Overview
Hims & Hers Health (HIMS) has been a standout performer in 2024, delivering an impressive 194.94% year-to-date return. The company has demonstrated significant growth momentum, driven by strong fundamentals and increasing investor confidence. The recent technical breakout highlights continued upside potential for the stock.
Current Price Analysis
• Current Price (Nov 22, 2024): $25.33
• Daily Change: +$1.18 (+4.89%)
• Post-Mar...

ecommerceshares

Nov 22 01:58

✨ RATINGS ALERT✨

$XPeng (XPEV.US)$ | Bernstein analyst Eunice Lee maintains XPeng with a hold rating, and adjusts the target price from $9 to $14.
$CrowdStrike (CRWD.US)$ | Stifel analyst Adam Borg maintains CrowdStrike Holdings with a Buy and raises the price target from $300 to $375.
$Alibaba (BABA.US)$ | Barclays analyst Jiong Shao maintains Alibaba with a buy rating, and adjusts the target price from $137 to $130.
$Robinhood (HOOD.US)$ | Bernstein analyst Gautam Chhugani maintain...

Earnings flood from China's stocks: Is a turnaround on the horizon?